CHRONIC AND COMPLEX MEDICINE
Endocrinology
The Chronic and Complex Medicine Network is a multidisciplinary network that includes diabetes and endocrinology, renal medicine, pain management and more recently chronic pulmonary disease and cardiac failure. These groups comprise lab based and clinical research. Across the network, the groups continue to produce high quality basic research that has led to publications in high impact journals and led to the securing of patents for original discovery. Important network partnerships include that with the Karolinska Institute and Massachusetts General Hospital, Stanford Pain Group, Monash Health, Melbourne Health, Baker Institute, Kings College, Walter and Eliza Hall Institute of Medical Research, JDRF Australia, National Institutes of Health, Peter McCallum Cancer Centre, UTS and NHMRC Clinical Trial Centre, the Endocrine Surgical Group, NSW Pathology and Macquarie University. The network research committee promotes the concept of “value in research” generally, providing an atmosphere in which those not schooled in research have a forum to become involved. The importance of embedding research into daily clinical practice is a focus.
The RNSH department of endocrinology was involved in more than 30 clinical trials and other research projects in 2020 in areas including diabetes, thyroid cancer, adrenal disease, osteoporosis, spinal cord injury and rare metabolic bone disease. Key research projects include: › Diabetes research: EXPECT, CREDENCE and CANVAS studies › Thyroid cancer: LIBRETTO-001 and COSMIC studies
› Adrenal diseases: PROSALDO study › Rare metabolic bone diseases: PVO
In 2020, the endocrinology department was also involved in conducting several COVID-19-related research projects, including the COVID-SHIELD trial, the ASCOT trial and the SMELLY study.
28
RESEARCH ANNUAL REPORT 2020
Made with FlippingBook - professional solution for displaying marketing and sales documents online